The article reports on the recommendations made by the House of Commons health select committee to improve the National Health Service's (NHS) inefficacies in diagnosing the value of money in Great Britain. The committee urges that data on consultancy spending should be brought together centrally....
New Tools for Evaluation : Their Application to Computers Expenditure on experimental computer application in NHS hospitals so far exceeds 26 million (see Committee of Public Accounts 1976) and expenditure on evaluation alone exceeds 750,000. The measures which have been used for evaluation of ......
(2002). Private finance and "value for money" in NHS hospitals: a policy in search of a rationale? British Medical Journal, 324(7347), 1205-1209. doi: 10.1136/bmj.324.7347.1205.Pollock AM, Shaoul J, Vickers N. Private finance and `value for money' in NHS hospitals: a policy in ...
The National Institute for Health and Care Excellence (NICE) judges which medicines offer value for money to the NHS. NICE currently has an upper cost-effectiveness threshold of £30,000 per quality-adjusted life year — a measure of the extra length and quality of life provided by a drug ...
Reports that the National Audit Office of Great Britain has found that the National Health Services' Local Improvement Finance Trust (LIFT) is a "value for money" way to build new general practitioner premises but ...
Private finance and "value for money" in NHS hospitals: a policy in search of a rationale? Health Policy and Health Services Research UnitJean ShaoulNeil VickersBritish Medical JournalPollock, A., Shaoul, J. & Vickers, N. (2002). Private Finance and `value for money' in NHS hospitals: a...
Getting better value from the NHS drug budget. James Moon and colleagues propose a way to restructure healthcare prescribing to get better value for money and persuade drug companies to invest in ... JC Moon,AS Flett,BB Godman,... - Bmj 被引量: 73发表: 2010年 Evaluating the NHS research...
The Institute previously said it could not recommend the drug for the entire MCL patient population as it did not offer the NHS value for money, but that, in the second-line setting, Imbruvica could be considered within ‘end-of-life’ thresholds and its cost effectiveness is likely to be ...
Legal requirements and practical support are in place to promote evidence-based policy and commissioning, including the 2012 Health and Social Care Act which created a statutory duty for the usage of research evidence to help improve patient outcomes and achieve value for money [14,15]. NHS Engla...
It wants to ensure a balance between delivering the best care and getting value for money for the taxpayer. Up to 48,000 people could use the apps, saving 145,000 hours of doctors' time, calculations by NICE show. The technology aims to provide support for those who are not able to att...